Skip to main content
Clinical Trials/DRKS00004966
DRKS00004966CompletedPhase 2

Clinical Phase II Trial of 5-Aminolevulinic Acid Hydrochloride (5-ALA, 5-ALS) for Fluorescence-Guided Resection of Malignant Glioma

medac, Gesellschaft für klinische Spezialpräparate mbH0 sites36 target enrollmentStarted: May 10, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
36

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • Suspected malignant glioma (WHO grades III or IV) according to MRI criteria
  • no prior tumor specific therapies
  • planned surgery

Exclusion Criteria

  • Porphyria or sensitivity to porphyrins
  • Renal or hepatic disease
  • Dementia or other cognitive disorders precluding informed consent

Investigators

Sponsor
medac, Gesellschaft für klinische Spezialpräparate mbH

Similar Trials

Not yet recruiting
Phase 2
To know the Safe and Effect of 5-aminolevulinic acid hydrochloride and Sodium Ferrous Citrate combination drug on Malaria Patients to treat malaria.
CTRI/2018/09/015824eopharma Japan Co Ltd
Completed
Not Applicable
The Safety and Efficacy of 5-Aminolevulinic Acid (ALA) Therapy for Sideroblastic AnemiaSideroblastic anemia (congenital and acquired)
JPRN-UMIN000023490Department of Hematolgy and Rheumatology, Tohoku University Graduate School of Medicine5
Active, not recruiting
Not Applicable
A pilot study into the effect of 5-Aminolevulinic Acid Photodynamic Therapy in the management of oral Lichen Planus - Pilot study into the use of PDT for Oral Lichen PlanusOral Lichen Planus
EUCTR2006-004696-35-GBGreater Glasgow and Clyde Health Board60
Active, not recruiting
Phase 1
Does 5-Aminolevulinic acid in combination with sodium ferrous citrate improve the strength of the heart beat following surgery using a heart lung machine?
EUCTR2015-001321-17-GBniversity of Oxford402
Active, not recruiting
Phase 1
5-Aminolevulinic acid (5-ALA) in children and adolescents with differnt types of brain tumoursintra-axial brain tumor (malignant glioma, astrocytoma, malignant ependymoma, AT/RT, Oligodendroglioma, etc.)MedDRA version: 20.0Level: LLTClassification code 10006154Term: Brain tumor NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-005669-54-DEniversität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Personal und Recht80
Clinical Phase II Trial of... | Clinical Trial